Chinese Covid-19 Vaccines Cleared for Final Testing in U.A.E.
- China National Biotec Group gets U.A.E. approval for testing
- World’s fast-moving shots approach final stage of trials
This article is for subscribers only.
A Chinese state-owned vaccine developer secured regulatory approval to test its coronavirus shots in the United Arab Emirates, making it one of the first among a slew of global efforts to get the greenlight for the final stage of human trials.
Beijing-based China National Biotec Group Co. was awarded approval on Tuesday to conduct Phase III trials for its Covid-19 vaccines in the Middle Eastern country, the company said in a statement posted on its official WeChat account.